- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.65 Å
- Oligo State
- hetero-12-12-mer
- Ligands
- 12 x SO4: SULFATE ION(Non-functional Binders)
- 64 x BME: BETA-MERCAPTOETHANOL(Non-functional Binders)
BME.2: 8 residues within 4Å:- Chain A: Y.56, D.57, G.60, R.188, I.189, Q.190, G.191, E.192
Ligand excluded by PLIPBME.10: 7 residues within 4Å:- Chain A: P.15, R.133
- Chain B: Y.24, T.26, W.149, I.191
- Ligands: BME.11
Ligand excluded by PLIPBME.11: 8 residues within 4Å:- Chain A: P.15, Y.16
- Chain B: Y.108, R.157, H.160, H.162
- Ligands: FE.4, BME.10
Ligand excluded by PLIPBME.12: 6 residues within 4Å:- Chain B: S.38, I.39, P.40
- Chain D: R.150, P.153
- Chain V: P.215
Ligand excluded by PLIPBME.13: 3 residues within 4Å:- Chain B: R.109, L.119, P.121
Ligand excluded by PLIPBME.18: 7 residues within 4Å:- Chain C: G.14, P.15, R.133
- Chain D: Y.24, T.26, W.149, I.191
Ligand excluded by PLIPBME.19: 7 residues within 4Å:- Chain C: P.15, Y.16
- Chain D: Y.108, R.157, H.160, H.162
- Ligands: FE.16
Ligand excluded by PLIPBME.20: 3 residues within 4Å:- Chain D: H.234, F.235
- Chain L: S.138
Ligand excluded by PLIPBME.21: 5 residues within 4Å:- Chain D: Q.203, I.205, R.222, F.223, D.224
Ligand excluded by PLIPBME.24: 8 residues within 4Å:- Chain E: Y.56, D.57, G.60, R.188, I.189, Q.190, G.191, E.192
Ligand excluded by PLIPBME.27: 4 residues within 4Å:- Chain F: H.234, F.235, E.236, C.238
Ligand excluded by PLIPBME.28: 7 residues within 4Å:- Chain E: P.15, Y.16
- Chain F: Y.108, R.157, H.160, H.162
- Ligands: FE.25
Ligand excluded by PLIPBME.29: 8 residues within 4Å:- Chain E: T.12, G.14, P.15, R.133
- Chain F: Y.24, T.26, W.149, I.191
Ligand excluded by PLIPBME.30: 3 residues within 4Å:- Chain F: T.21, P.22, D.23
Ligand excluded by PLIPBME.31: 4 residues within 4Å:- Chain F: R.222, F.223, D.224
- Chain I: I.2
Ligand excluded by PLIPBME.32: 3 residues within 4Å:- Chain F: F.56, C.129, L.130
Ligand excluded by PLIPBME.37: 8 residues within 4Å:- Chain G: T.12, G.14, P.15, R.133
- Chain H: Y.24, T.26, W.149, I.191
Ligand excluded by PLIPBME.38: 5 residues within 4Å:- Chain H: Q.203, I.205, R.222, F.223, D.224
Ligand excluded by PLIPBME.39: 3 residues within 4Å:- Chain H: F.56, C.129, L.130
Ligand excluded by PLIPBME.40: 7 residues within 4Å:- Chain G: P.15, Y.16
- Chain H: Y.108, R.157, H.160, H.162
- Ligands: FE.35
Ligand excluded by PLIPBME.41: 3 residues within 4Å:- Chain H: R.107, P.118, L.119
Ligand excluded by PLIPBME.42: 4 residues within 4Å:- Chain H: N.154, D.155, M.188
- Chain T: M.210
Ligand excluded by PLIPBME.43: 3 residues within 4Å:- Chain H: T.233, H.234, F.235
Ligand excluded by PLIPBME.44: 3 residues within 4Å:- Chain H: R.109, L.119, P.121
Ligand excluded by PLIPBME.49: 7 residues within 4Å:- Chain I: G.14, P.15, R.133
- Chain J: Y.24, T.26, W.149, I.191
Ligand excluded by PLIPBME.50: 6 residues within 4Å:- Chain J: Q.202, Q.203, I.205, R.222, F.223, D.224
Ligand excluded by PLIPBME.51: 7 residues within 4Å:- Chain I: P.15, Y.16
- Chain J: Y.108, R.157, H.160, H.162
- Ligands: FE.47
Ligand excluded by PLIPBME.52: 3 residues within 4Å:- Chain J: F.56, C.129, L.130
Ligand excluded by PLIPBME.57: 7 residues within 4Å:- Chain K: G.14, P.15, R.133
- Chain L: Y.24, T.26, W.149, I.191
Ligand excluded by PLIPBME.58: 4 residues within 4Å:- Chain L: H.234, F.235, E.236, C.238
Ligand excluded by PLIPBME.59: 8 residues within 4Å:- Chain K: G.14, P.15, Y.16
- Chain L: Y.108, R.157, H.160, H.162
- Ligands: FE.55
Ligand excluded by PLIPBME.60: 5 residues within 4Å:- Chain C: I.2
- Chain L: K.207, R.222, F.223, D.224
Ligand excluded by PLIPBME.62: 8 residues within 4Å:- Chain M: Y.56, D.57, G.60, R.188, I.189, Q.190, G.191, E.192
Ligand excluded by PLIPBME.70: 7 residues within 4Å:- Chain M: P.15, R.133
- Chain N: Y.24, T.26, W.149, I.191
- Ligands: BME.71
Ligand excluded by PLIPBME.71: 8 residues within 4Å:- Chain M: P.15, Y.16
- Chain N: Y.108, R.157, H.160, H.162
- Ligands: FE.64, BME.70
Ligand excluded by PLIPBME.72: 6 residues within 4Å:- Chain J: P.215
- Chain N: S.38, I.39, P.40
- Chain P: R.150, P.153
Ligand excluded by PLIPBME.73: 3 residues within 4Å:- Chain N: R.109, L.119, P.121
Ligand excluded by PLIPBME.78: 7 residues within 4Å:- Chain O: G.14, P.15, R.133
- Chain P: Y.24, T.26, W.149, I.191
Ligand excluded by PLIPBME.79: 7 residues within 4Å:- Chain O: P.15, Y.16
- Chain P: Y.108, R.157, H.160, H.162
- Ligands: FE.76
Ligand excluded by PLIPBME.80: 3 residues within 4Å:- Chain P: H.234, F.235
- Chain X: S.138
Ligand excluded by PLIPBME.81: 5 residues within 4Å:- Chain P: Q.203, I.205, R.222, F.223, D.224
Ligand excluded by PLIPBME.84: 8 residues within 4Å:- Chain Q: Y.56, D.57, G.60, R.188, I.189, Q.190, G.191, E.192
Ligand excluded by PLIPBME.87: 4 residues within 4Å:- Chain R: H.234, F.235, E.236, C.238
Ligand excluded by PLIPBME.88: 7 residues within 4Å:- Chain Q: P.15, Y.16
- Chain R: Y.108, R.157, H.160, H.162
- Ligands: FE.85
Ligand excluded by PLIPBME.89: 8 residues within 4Å:- Chain Q: T.12, G.14, P.15, R.133
- Chain R: Y.24, T.26, W.149, I.191
Ligand excluded by PLIPBME.90: 3 residues within 4Å:- Chain R: T.21, P.22, D.23
Ligand excluded by PLIPBME.91: 4 residues within 4Å:- Chain R: R.222, F.223, D.224
- Chain U: I.2
Ligand excluded by PLIPBME.92: 3 residues within 4Å:- Chain R: F.56, C.129, L.130
Ligand excluded by PLIPBME.97: 8 residues within 4Å:- Chain S: T.12, G.14, P.15, R.133
- Chain T: Y.24, T.26, W.149, I.191
Ligand excluded by PLIPBME.98: 5 residues within 4Å:- Chain T: Q.203, I.205, R.222, F.223, D.224
Ligand excluded by PLIPBME.99: 3 residues within 4Å:- Chain T: F.56, C.129, L.130
Ligand excluded by PLIPBME.100: 7 residues within 4Å:- Chain S: P.15, Y.16
- Chain T: Y.108, R.157, H.160, H.162
- Ligands: FE.95
Ligand excluded by PLIPBME.101: 3 residues within 4Å:- Chain T: R.107, P.118, L.119
Ligand excluded by PLIPBME.102: 4 residues within 4Å:- Chain H: M.210
- Chain T: N.154, D.155, M.188
Ligand excluded by PLIPBME.103: 3 residues within 4Å:- Chain T: T.233, H.234, F.235
Ligand excluded by PLIPBME.104: 3 residues within 4Å:- Chain T: R.109, L.119, P.121
Ligand excluded by PLIPBME.109: 7 residues within 4Å:- Chain U: G.14, P.15, R.133
- Chain V: Y.24, T.26, W.149, I.191
Ligand excluded by PLIPBME.110: 6 residues within 4Å:- Chain V: Q.202, Q.203, I.205, R.222, F.223, D.224
Ligand excluded by PLIPBME.111: 7 residues within 4Å:- Chain U: P.15, Y.16
- Chain V: Y.108, R.157, H.160, H.162
- Ligands: FE.107
Ligand excluded by PLIPBME.112: 3 residues within 4Å:- Chain V: F.56, C.129, L.130
Ligand excluded by PLIPBME.117: 7 residues within 4Å:- Chain W: G.14, P.15, R.133
- Chain X: Y.24, T.26, W.149, I.191
Ligand excluded by PLIPBME.118: 4 residues within 4Å:- Chain X: H.234, F.235, E.236, C.238
Ligand excluded by PLIPBME.119: 8 residues within 4Å:- Chain W: G.14, P.15, Y.16
- Chain X: Y.108, R.157, H.160, H.162
- Ligands: FE.115
Ligand excluded by PLIPBME.120: 5 residues within 4Å:- Chain O: I.2
- Chain X: K.207, R.222, F.223, D.224
Ligand excluded by PLIP- 10 x TRS: 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL(Non-functional Binders)
TRS.3: 7 residues within 4Å:- Chain A: E.168, T.169, I.171, R.184, F.185, D.186, R.188
10 PLIP interactions:10 interactions with chain A- Hydrogen bonds: A:T.169, A:I.171, A:R.184, A:D.186, A:R.188
- Water bridges: A:E.168, A:I.171, A:I.171, A:D.186, A:R.188
TRS.15: 7 residues within 4Å:- Chain C: E.168, T.169, I.171, R.184, F.185, D.186, R.188
8 PLIP interactions:8 interactions with chain C- Hydrogen bonds: C:E.168, C:T.169, C:I.171, C:D.186, C:R.188, C:R.188
- Water bridges: C:D.186, C:D.186
TRS.34: 6 residues within 4Å:- Chain G: T.169, I.171, R.184, F.185, D.186, R.188
6 PLIP interactions:6 interactions with chain G- Hydrogen bonds: G:T.169, G:I.171, G:I.171, G:R.184, G:D.186, G:R.188
TRS.46: 8 residues within 4Å:- Chain I: E.168, T.169, I.171, A.172, R.184, F.185, D.186, R.188
6 PLIP interactions:6 interactions with chain I- Hydrogen bonds: I:I.171, I:R.184, I:D.186, I:R.188, I:R.188
- Water bridges: I:D.186
TRS.54: 8 residues within 4Å:- Chain K: E.168, T.169, I.171, A.172, R.184, F.185, D.186, R.188
10 PLIP interactions:10 interactions with chain K- Hydrogen bonds: K:T.169, K:I.171, K:R.184, K:D.186, K:R.188
- Water bridges: K:E.168, K:I.171, K:I.171, K:D.186, K:R.188
TRS.63: 7 residues within 4Å:- Chain M: E.168, T.169, I.171, R.184, F.185, D.186, R.188
9 PLIP interactions:9 interactions with chain M- Hydrogen bonds: M:T.169, M:I.171, M:R.184, M:D.186, M:R.188
- Water bridges: M:E.168, M:I.171, M:I.171, M:R.188
TRS.75: 7 residues within 4Å:- Chain O: E.168, T.169, I.171, R.184, F.185, D.186, R.188
7 PLIP interactions:7 interactions with chain O- Hydrogen bonds: O:E.168, O:T.169, O:I.171, O:D.186, O:R.188, O:R.188
- Water bridges: O:D.186
TRS.94: 6 residues within 4Å:- Chain S: T.169, I.171, R.184, F.185, D.186, R.188
6 PLIP interactions:6 interactions with chain S- Hydrogen bonds: S:T.169, S:I.171, S:I.171, S:R.184, S:D.186, S:R.188
TRS.106: 8 residues within 4Å:- Chain U: E.168, T.169, I.171, A.172, R.184, F.185, D.186, R.188
5 PLIP interactions:5 interactions with chain U- Hydrogen bonds: U:I.171, U:R.184, U:D.186, U:R.188, U:R.188
TRS.114: 8 residues within 4Å:- Chain W: E.168, T.169, I.171, A.172, R.184, F.185, D.186, R.188
9 PLIP interactions:9 interactions with chain W- Hydrogen bonds: W:T.169, W:I.171, W:R.184, W:D.186, W:R.188
- Water bridges: W:E.168, W:I.171, W:I.171, W:R.188
- 12 x FE: FE (III) ION(Non-covalent)
FE.4: 4 residues within 4Å:- Chain B: Y.108, H.160, H.162
- Ligands: BME.11
3 PLIP interactions:3 interactions with chain B- Metal complexes: B:Y.108, B:H.160, B:H.162
FE.16: 4 residues within 4Å:- Chain D: Y.108, H.160, H.162
- Ligands: BME.19
3 PLIP interactions:3 interactions with chain D- Metal complexes: D:Y.108, D:H.160, D:H.162
FE.25: 4 residues within 4Å:- Chain F: Y.108, H.160, H.162
- Ligands: BME.28
3 PLIP interactions:3 interactions with chain F- Metal complexes: F:Y.108, F:H.160, F:H.162
FE.35: 4 residues within 4Å:- Chain H: Y.108, H.160, H.162
- Ligands: BME.40
3 PLIP interactions:3 interactions with chain H- Metal complexes: H:Y.108, H:H.160, H:H.162
FE.47: 4 residues within 4Å:- Chain J: Y.108, H.160, H.162
- Ligands: BME.51
3 PLIP interactions:3 interactions with chain J- Metal complexes: J:Y.108, J:H.160, J:H.162
FE.55: 4 residues within 4Å:- Chain L: Y.108, H.160, H.162
- Ligands: BME.59
3 PLIP interactions:3 interactions with chain L- Metal complexes: L:Y.108, L:H.160, L:H.162
FE.64: 4 residues within 4Å:- Chain N: Y.108, H.160, H.162
- Ligands: BME.71
3 PLIP interactions:3 interactions with chain N- Metal complexes: N:Y.108, N:H.160, N:H.162
FE.76: 4 residues within 4Å:- Chain P: Y.108, H.160, H.162
- Ligands: BME.79
3 PLIP interactions:3 interactions with chain P- Metal complexes: P:Y.108, P:H.160, P:H.162
FE.85: 4 residues within 4Å:- Chain R: Y.108, H.160, H.162
- Ligands: BME.88
3 PLIP interactions:3 interactions with chain R- Metal complexes: R:Y.108, R:H.160, R:H.162
FE.95: 4 residues within 4Å:- Chain T: Y.108, H.160, H.162
- Ligands: BME.100
3 PLIP interactions:3 interactions with chain T- Metal complexes: T:Y.108, T:H.160, T:H.162
FE.107: 4 residues within 4Å:- Chain V: Y.108, H.160, H.162
- Ligands: BME.111
3 PLIP interactions:3 interactions with chain V- Metal complexes: V:Y.108, V:H.160, V:H.162
FE.115: 4 residues within 4Å:- Chain X: Y.108, H.160, H.162
- Ligands: BME.119
3 PLIP interactions:3 interactions with chain X- Metal complexes: X:Y.108, X:H.160, X:H.162
- 18 x CL: CHLORIDE ION(Non-functional Binders)
CL.5: 4 residues within 4Å:- Chain B: K.25, T.26, I.28, A.29
Ligand excluded by PLIPCL.6: 2 residues within 4Å:- Chain B: H.234, F.235
Ligand excluded by PLIPCL.7: 2 residues within 4Å:- Chain B: C.129, L.130
Ligand excluded by PLIPCL.8: 1 residues within 4Å:- Chain B: R.83
Ligand excluded by PLIPCL.17: 1 residues within 4Å:- Chain D: R.83
Ligand excluded by PLIPCL.26: 1 residues within 4Å:- Chain F: R.83
Ligand excluded by PLIPCL.36: 1 residues within 4Å:- Chain H: R.83
Ligand excluded by PLIPCL.48: 1 residues within 4Å:- Chain J: R.83
Ligand excluded by PLIPCL.56: 1 residues within 4Å:- Chain L: R.83
Ligand excluded by PLIPCL.65: 4 residues within 4Å:- Chain N: K.25, T.26, I.28, A.29
Ligand excluded by PLIPCL.66: 2 residues within 4Å:- Chain N: H.234, F.235
Ligand excluded by PLIPCL.67: 2 residues within 4Å:- Chain N: C.129, L.130
Ligand excluded by PLIPCL.68: 1 residues within 4Å:- Chain N: R.83
Ligand excluded by PLIPCL.77: 1 residues within 4Å:- Chain P: R.83
Ligand excluded by PLIPCL.86: 1 residues within 4Å:- Chain R: R.83
Ligand excluded by PLIPCL.96: 1 residues within 4Å:- Chain T: R.83
Ligand excluded by PLIPCL.108: 1 residues within 4Å:- Chain V: R.83
Ligand excluded by PLIPCL.116: 1 residues within 4Å:- Chain X: R.83
Ligand excluded by PLIP- 4 x GOL: GLYCEROL(Non-functional Binders)
GOL.9: 7 residues within 4Å:- Chain B: Q.203, I.205, K.207, R.222, F.223, D.224
- Chain Q: I.2
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:Q.203, B:D.224, B:D.224
GOL.23: 7 residues within 4Å:- Chain E: E.168, T.169, I.171, R.184, F.185, D.186, R.188
4 PLIP interactions:4 interactions with chain E- Hydrogen bonds: E:E.168, E:R.184, E:D.186, E:R.188
GOL.69: 7 residues within 4Å:- Chain E: I.2
- Chain N: Q.203, I.205, K.207, R.222, F.223, D.224
3 PLIP interactions:3 interactions with chain N- Hydrogen bonds: N:Q.203, N:D.224, N:D.224
GOL.83: 7 residues within 4Å:- Chain Q: E.168, T.169, I.171, R.184, F.185, D.186, R.188
4 PLIP interactions:4 interactions with chain Q- Hydrogen bonds: Q:E.168, Q:R.184, Q:D.186, Q:R.188
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Purpero, V.M. et al., Tyrosine 447 of Protocatechuate 3,4-Dioxygenase Controls Efficient Progress Through Catalysis. To be Published
- Release Date
- 2011-02-23
- Peptides
- Protocatechuate 3,4-dioxygenase alpha chain: ACEGIKMOQSUW
Protocatechuate 3,4-dioxygenase beta chain: BDFHJLNPRTVX - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
BE
CG
DI
EK
FM
AO
BQ
CS
DU
EW
FB
MD
NF
OH
PJ
QL
RN
MP
NR
OT
PV
QX
R
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.65 Å
- Oligo State
- hetero-12-12-mer
- Ligands
- 12 x SO4: SULFATE ION(Non-functional Binders)
- 64 x BME: BETA-MERCAPTOETHANOL(Non-functional Binders)
- 10 x TRS: 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL(Non-functional Binders)
- 12 x FE: FE (III) ION(Non-covalent)
- 18 x CL: CHLORIDE ION(Non-functional Binders)
- 4 x GOL: GLYCEROL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Purpero, V.M. et al., Tyrosine 447 of Protocatechuate 3,4-Dioxygenase Controls Efficient Progress Through Catalysis. To be Published
- Release Date
- 2011-02-23
- Peptides
- Protocatechuate 3,4-dioxygenase alpha chain: ACEGIKMOQSUW
Protocatechuate 3,4-dioxygenase beta chain: BDFHJLNPRTVX - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
BE
CG
DI
EK
FM
AO
BQ
CS
DU
EW
FB
MD
NF
OH
PJ
QL
RN
MP
NR
OT
PV
QX
R